PBAC Public Summary Documents - November 2010

Public summary documents relating to the November 2010 PBAC meeting

Page last updated: 17 March 2011

• Adalimumab, injection, 40 mg in 0.8 mL, pre-filled syringe, pre-filled pen, Humira®, November 2010
• Adapalene with benzoyl peroxide, gel, 1 mg – 25 mg per g (0.1%-2.5%), 30 g, Epiduo®, November 2010
• Agomelatine, tablet, 25 mg, Valdoxan®, November 2010
• Alglucosidase alfa, powder for I.V. infusion, 50 mg, Myozyme®, November 2010
• Aztreonam, powder for inhalation, 75 mg (as lysine), with diluent, Cayston®, November 2010
• Bevacizumab, solution for intravenous infusion, 100 mg in 4 mL and 400 mg in 16 mL, Avastin®, November 2010
• Budesonide with eformoterol fumarate dihydrate, powder for oral inhalation, fixed dose combination, 400 micrograms-12 micrograms per dose, Symbicort Turbuhaler 400/12®, November 2010
• Corifollitropin alfa, solution for injection, 100 micrograms in 0.5 mL, 150 micrograms in 0.5 mL, pre-filled syringe, Elonva®, November 2010
• Dalteparin sodium (low molecular weight heparin sodium-porcine mucous), injection, 7,500 units (anti-Xa) in 0.75 mL, 10,000 units (anti-Xa) in 1 mL, 12,500 units (anti-Xa) in 0.5 mL, 15,000 units (anti-Xa) in 0.6 mL and 18,000 units (anti-Xa) in 0.72 mL, single dose pre-filled syringe, Fragmin®, November 2010
• Dronedarone hydrochloride, tablet, 400 mg, Multaq®, November 2010
• Dutasteride with tamsulosin hydrochloride, capsule, 500 micrograms – 400 micrograms, Duodart®, November 2010
• Eltrombopag olamine, tablets, 25 mg and 50 mg, Revolade®, November 2010
• Ezetimibe, tablet, 10 mg, Ezetrol®, November 2010
• Filgrastim, injection, 120 micrograms in 0.2 mL single use pre-filled syringe, 300 micrograms in 0.5 mL single use pre-filled syringe, 480 micrograms in 0.5 mL single use pre-filled syringe, Nivestim®, November 2010
• Gefitinib, tablet, 250 mg, Iressa®, November 2010
• Haemophilus influenzae type b and group c meningococcal polysaccharide conjugate vaccine, lyophilised powder for injection, 1 vial with 0.5 mL pre-filled syringe diluent, 10 vials with 10 0.5 mL pre-filled syringe diluent, Menitorix®, November 2010
• Indacaterol maleate, capsules containing powder for oral inhalation, 150 microgram (base) and 300 microgram (base), Onbrez® Breezhaler®, November 2010
• Levodopa with carbidopa (as monohydrate), intestinal gel, 20 mg – 5 mg (base) per mL, 100 mL, Duodopa®, November 2010
• Liraglutide (rys), solution for injection, 3 mL pre-filled injection pen, 6 mg per mL, Victoza®, November 2010
• Omalizumab (rch), powder for injection, 150 mg, Xolair®, November 2010
• Omega-3-acid ethyl esters 90, soft capsule, 1,000 mg, Omacor®, November 2010
• Oxycodone hydrochloride with naloxone hydrochloride dihydrate, controlled release tablet, 5 mg-2.5 mg, 10 mg-5 mg, 20 mg-10 mg and 40 mg-20 mg, Targin®, November 2010
• Paliperidone palmitate, aqueous suspension for injection, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg, pre-filled syringe, Invega® Sustenna™, November 2010
• Plerixafor, solution for subcutaneous injection, 20 mg per mL, 1.2 mL, Mozobil®, November 2010
• Pneumococcal polysaccharide conjugate vaccine, 13-valent adsorbed, pre-filled syringe, 0.5 mL, Prevenar 13®, November 2010
• Quetiapine, tablets, 25 mg, 100 mg, 200 mg and 300 mg (as fumarate), Seroquel®, and tablets (modified release), 50 mg, 200 mg, 300 mg and 400 mg (as fumarate), Seroquel XR® (depressive episodes), November 2010)
• Quetiapine, tablets, 25 mg, 100 mg, 200 mg and 300 mg (as fumarate), Seroquel®, and tablets (modified release), 50 mg, 200 mg, 300 mg and 400 mg (as fumarate), Seroquel XR® (mania), November 2010
• Rituximab, solution for I.V infusion, 100 mg in 10 mL, 500 mg in 50 mL, Mabthera®, November 2010
• Tamsulosin hydrochloride, tablet (prolonged release), 400 microgram, Flomaxtra®, November 2010